Study of TGM-312-SC01 in Healthy Participants and Adults With MASH

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamic (PD) effects of single ascending doses of TGM-312-SC01 in healthy adults and multiple ascending doses in patients with metabolic dysfunction-associated steatohepatitis (MASH).
Epistemonikos ID: 50dffca2d8a0b848e3d597b576cbde26cd1e5206
First added on: Feb 24, 2026